Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).

Saved in:
Bibliographic Details
Title: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
Authors: Qaseem A; American College of Physicians, Philadelphia, Pennsylvania (A.Q., I.E.)., Yost J; American College of Physicians, Philadelphia, and Villanova University, Villanova, Pennsylvania (J.Y.)., Etxeandia-Ikobaltzeta I; American College of Physicians, Philadelphia, Pennsylvania (A.Q., I.E.)., Abraham GM; University of Massachusetts Medical School and Saint Vincent Hospital, Worcester, Massachusetts (G.M.A.)., Jokela JA; University of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois (J.A.J.)., Forciea MA; Penn Medicine, Philadelphia, Pennsylvania (M.A.F., M.C.M.)., Miller MC; Penn Medicine, Philadelphia, Pennsylvania (M.A.F., M.C.M.)., Humphrey LL; Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon (L.L.H.)., Centor RM, Andrews R, Haeme R, Kansagara DL, Marcucci M
Corporate Authors: Scientific Medical Policy Committee of the American College of Physicians
Source: Annals of internal medicine [Ann Intern Med] 2021 Feb; Vol. 174 (2), pp. 229-236. Date of Electronic Publication: 2020 Oct 05.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1539-3704
DOI:10.7326/M20-5831